Procter & Gamble stock seen rising 10.57% to $160.50 amid tariff pressures and strong segment growth.

Procter & Gamble shares are trading 13.3% below their 52-week high, with a price target of $160.50 indicating a 10.57% upside. Despite a recent year-long decline and tariff-related costs impacting operating income, the company shows strength in its Beauty and Health Care segments, which grew 5% organically in Q2 FY26. The firm plans significant dividend and buyback returns, supported by a 69-year dividend increase streak. Risks include ongoing tariff costs, soft volume trends, and a weak Baby segment, but the stock’s low volatility and 2.85% dividend yield provide stability while awaiting recovery.